[Evaluation of medication risk in pregnant women: methodology of evaluation and risk management].
This round table discussion was devoted to the description of the tools currently available for the evaluation of drug risks and management during pregnancy. Five topics were submitted for discussion: pre-clinical data, methodological tools, benefit/risk ratio before prescription, teratogenic or fetal risk evaluation, legal comments.
Eléfant
E
E
Centre de Renseignements sur les Agents Tératogènes. Laboratoire d'Embryologie Pathologique et de Cytogénétique, CHU Saint-Antoine.
Sainte-Croix
A
A
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005544:Forecasting; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D018570:Risk Assessment; D012308:Risk Management